The effects of intracarotid injection of the stable enkephalin analogue (D-Met2 ,Pr05)-enkephalin amide (ENK) and intravenous administration of naloxone on the cerebrocortical blood flow (dye dilution method) and cerebral blood volume (CBV) (photoelectric method) were investigated during unilateral brain ischemia in anesthetized cats. Both parameters were measured si multaneously in the intact and ischemic (middle cerebral artery occluded) hemispheres. An intracarotid injection of ENK 0.5 mg/kg induced a significant increase in cor tical vascular resistance and a -87% decrease in cere brocortical blood flow from 25 ± 3 to 4 ± 3 mJ/ lOO g/min, without CBV alteration in the ischemic hemisphere. Nal oxone (1 mg/kg i. v.), on the other hand, induced a marked two-fold increase in cerebrocortical blood flow Baskin and Hosobuchi (1981) and Hosobuchi et al. (1982a) suggested that endogenous opioids might play an important role in the pathophysiology of cerebral ischemia. They found that the opiate an tagonist naloxone reversed hemiplegia and im proved speech in patients suffering from cerebral ischemia. Naloxone also improved the neurological functions and survival of gerbils following stroke vakia.
and a significant elevation of CBV from 5.9 ± 0.5 to 7.4 ± 0.7 vol% in the ischemic hemisphere. No change in cerebrocortical blood flow or CBV was observed in the intact hemisphere either after ENK or after naloxone ad ministration. Arterial blood gases and hematocrit re mained unchanged. On the basis of the present findings, we conclude that (a) besides other factors, endogenous opioid mechanisms may also participate in ischemic cere brovascular reactions and (b) the cerebral circulatory ef fects of naloxone probably reflect its opiate receptor blocking property and not simply its other non-opiate related actions. Key Words: Brain ischemia-Cerebral blood flow-Cerebral blood volume-(D-Met2,Pr05)-En kephalinamide-N aloxone-Opiate receptors.
induced by carotid occlusion. These findings gener ated wide interest and several articles appeared on this topic, reporting both success in using naloxone in cerebral ischemia (Baskin et aI. , 1982; Faden et aI. , 1982; Levy et aI., 1982; Pietronigro et aI., 1983; Zambramski et aI., 1983) as well as failure (Holaday and D'Amato, 1982a,b; Kastin et aI. , 1982; Hub bard and Sundt, 1983; Claperon et aI. , 1983; Fallis et aI., 1983; Nehls et aI., 1983) . Faden et al. (1981) observed that [3-endorphin like immunoreactivity was significantly elevated following experimental spinal injury and that nal oxone improved the spinal cord blood flow and fa cilitated subsequent neurological recovery. A simi larity was suggested between the pathophysiology of spinal cord injury and cerebral ischemia (Faden, 1983) . On the basis of such a similarity, it might be hypothesized that increased endogenous opioid ac tivity in both conditions (Faden et aI. , 1981; Hoso buchi et aI., 1982a,b) could result in a critical re-duction of the CBF leading to functional neurolog ical deficits. The possibility exists, therefore, that the beneficial effects of naloxone are based on a blockade of increased endogenous opioid activity and consequently on a subsequent improvement in tissue CBF.
Since naloxone is widely recognized as a highly specific opiate antagonist, the above hypothesis could be correct. There is the problem, however, that one needs a relatively high dose of naloxone in order to block not only f.L-receptors, the specific re ceptor type for exogenous morphine action, but also 8, K, and E-receptors, the specific receptor types for the main endogenous opioid peptides en kephalin, dynorphin, and f3-endorphin, respec tively. On the other hand, at high doses naloxone also exerts effects that may not be opiate receptor mediated (Sawynok et aI. , 1979; Koreh et aI. , 1981; Badawy et a!. , 1983; Brandt et a!. , 1983; Faden, 1984) . The question remains, therefore, of whether naloxone-induced improvements in cerebral isch emia are a result of its opiate receptor blocking ca pacity or a consequence of certain side effects having nothing to do with endogenous opioid pep tides.
It has been reported that exogenous morphine led to markedly worsened ischemic neurological deficits in humans (Hosbuchi et a!. , 1982h) . The data appear to provide indirect support for the above theory. In the only study on the effects of an endogenous opioid peptide analogue during brain ischemia, however, Sandoz FK 33824 exhibited no effect in gerbils with unilateral carotid artery liga tion (Hosobuchi et a!. , 1982a) .
In the present study we attempted to show that another analogue of Met-enkephalin, the stable, long-acting (D-Met2 ,Pro5)-enkephalinamide (ENK), could produce a similar effect to exogenous mor phine and an opposite effect to naloxone in brain ischemia. Intracarotid administration of this pep tide resulted in a further decrease of the already re duced CBF during experimentally induced, unilat eral brain ischemia in anesthetized cats.
METHODS
Eleven cats of both sexes weighing 2.1-4.1 kg were anesthetized intraperitoneally with a combination of 50 mg/kg a-chloralose and 500 mg/kg urethane. The animals were artifically ventilated through a tracheal cannula (model 662) after immobilization with alcuronium chlo ride. The femoral artery and femoral vein were catheter ized to monitor the systemic arterial blood pressure (Gould Statham P23 lD pressure transducer; Gould Statham Instruments Inc., Puerto Rico) and to administer muscle relaxant and naloxone, respectively. A thin poly ethylene catheter was inserted into the carotid artery via J Cereb Blood Flow Metab, Vol. 6, No.5, 1986 the lingual artery for ENK administration. This same ar tery was used for repeated manual injections of carbon black solution (Gunther Wagner, Pelikan Werke, Han nover, ER.G.) to produce indicator dilution curves in the tissue of both hemispheres for cortical blood flow deter minations.
The cerebral blood volume (CBV) was recorded con tinuously by the photoelectric method developed in our laboratory and described elsewhere (Tomita et aI., 1978 (Tomita et aI., , 1983 . In short a pair of photoelectric units were attached to the two cerebral hemispheres so that the focal CBV in a thin cerebrocortical tissue layer supplied by the middle cerebral artery (MCA) could be monitored on both sides in situ. Each photoelectric unit consisted of two ele ments: a photo-sensing silicon photodiode (Silicon blue cell SBC-55; Sharp Electric Co. , To kyo, Japan) fixed with dental cement into the excavated parietal skull bone without penetrating the skull cavity; and a light source consisting of a 0.7 -mm-diameter small lamp (Hamai Elec tric Co., To kyo, Japan), which was introduced into the cerebral tissue below the cortex, opposite the photo diode, and fixed in position to the skull with dental ce ment. Under given conditions the intensity of light pro duced by the lamp and detected by the photodiode is dependent solely on the blood content in the transillu minated brain tissue between the lamp and the photo diode. The light intensity can be quantified for CBV in percentage of volume and can be recorded continuously on a recorder. Records from the present study were scaled for relative changes of CBV, assuming that the light extinction of the blood was 1.2, the control value of CBV was 6.3 vol%, and the influence of aggregate forma tion by red blood cells could be neglected, as reported previously (Tomita et aI., 1980) . The thickness of the tissue layer between the light source and the photodiode (for the L value) was measured at autopsy. The CBF in both hemispheres was estimated from frequently pro duced dye dilution curves following 0.2-ml intracarotid carbon black injections. The dilution curves were de tected with the same photo-sensing units as mentioned above and were recorded on a multichannel recorder (Ri kadenki, model R-56M3; Rikadenki Kogyo Co., Ltd., To kyo, Japan). Va lues of the mean transit time (t) ob tained from the dilution curves by the area-over-height method were used for calculation of the local cortical blood flow as cortical blood flow = 60 . CBV It.
Occlusion of the MCA at its origin was performed transorbitally with a minature Mayfield clip during con tinuous recording of CBV in the core area of the ischemic region and simultaneously from the corresponding area of the opposite, intact hemisphere. In this way successful MCA occlusion was always confirmed from the imme diate fall in CBV in the hemisphere ipsilateral to the MCA occlusion. The orbit was closed in a water-tight manner with dental cement after clipping the artery. The total du ration of the operative procedure averaged � 3 h. Cats showing a significant unilateral CBV decrease after MCA occlusion were divided into two groups: ENK-treated animals (n = 7) and naloxone-treated animals (n = 9). In the ENK-treated group, 0.5 mg/kg intracarotid ENK (synthesized and supplied by the Institute of Drug Re search, Budapest, Hungary, and dissolved in saline) was given in I min at �60 min after MCA occlusion. CBF measurements were frequently repeated and CBV was continuously recorded both before and after the ENK administration in the ischemic and in the intact "control" hemispheres, simultaneously. In the naloxone-treated group, 1.0 mg/kg naloxone (naloxone hydrochloride dis solved in saline; Endo Laboratories Inc., Garden City, NY, U.S.A.) was injected intravenously in 1 min at �90 min after MCA occlusion. The number of animals in this group (n = 9) included those six cats that had been pre viously injected with ENK. The blood gases and hemato crit of arterial blood were measured before and after ENK administration in three separate cats, using a pHI blood gas analyzer (Radiometer BMS3 MK2, Copen hagen, Denmark) and a micropipet technique (Kubota KH-120, To kyo, Japan).
Autopsies were performed in all cats at the end of the experiment for macroscopic estimation of the brain swelling and for measurement of the depth of the lamp in the brain tissue, i.e., the thickness of the transilluminated cerebral tissue layer. Statistical analysis of the data was carried out by Bonferroni's modification of Student's paired two-tailed t test.
RESULTS

Effects of naloxone on cortical blood flow and CBV
In the ischemic hemisphere (at 90 min after MCA occlusion), 1 mg/kg i. v. naloxone resulted in a marked, approximately twofold increase in the cor tical blood flow ( Fig. 1; Ta ble 1) . The 53 ± 6 ml/IOO gimin resting cortical blood flow value was reduced by MCA occlusion to 18 ± 3 ml/l00 g/min but showed a significant elevation to 34 ± 5 mlllOO g/min (p < 0. 02) following the naloxone injection. This change was associated with an increase in sys temic arterial pressure from 96 ± 9 to 123 ± 14 mm Hg. The cortical vascular resistance decreased from 16.6 ± 9.5 to 4.6 ± 1. 1 mm Hg/mi/IOO g/min, although the change did not reach the level of sta tistical significance. The CBV in the ischemic hemi sphere exhibited a significant elevation from 5.9 ± 0. 5 to 7.4 ± 0.7 vol% (p < 0.001) following the nal oxone administration. In the intact brain hemi- sphere, simultaneously with these changes, there were not significant alterations in either CBF or CBV under the influence of the intravenous nal oxone administration ( Fig. 1; Ta ble 1 ).
Effects of ENK on cortical blood flow and CBV
In the ischemic brain hemisphere (at 60 min after MCA occlusion), 0. 5 mg/kg intracarotid ENK ad ministration was followed by an 87% reduction in the cortical blood flow, from a control value of 25 ± 3 to 4 ± 3 mlllOO g/min (p < 0.01), as shown in Fig. 2 and Ta ble 2. Simultaneously with this change the mean arterial pressure decreased from 102 ± 8 to 68 ± 5 mm Hg (p < 0. 001) and the vascular re sistance in the ischemic brain cortex increased from 18.1 ± 13.9 to 60. 2 ± 10. 9 mm Hg/mIlI00 g/min (p < 0.05) ( Table 2 ). The CBV of the ischemic hemisphere, however, was not significantly in fluenced by the intracarotid ENK administration. The intact brain hemisphere was affected by the same fall in systemic arterial pressure following ENK administration as the ischemic hemisphere.
In spite of this, neither the cortical blood flow nor the cortical vascular resistance revealed statisti cally significant alterations, although the latter did exhibit an increasing tendency and the former a de creasing tendency ( Table 2 ). The CBV in the intact hemisphere also remained essentially unchanged following the ENK injection.
There was little change in arterial P02 (93. 8 ± 4. 8 to 95. 6 ± 2.0 mm Hg), arterial Pco2 (26.9 ± 4. 3 to 28. 9 ± 5.2 mm Hg), and arterial pH (7.248 ± 0.03 to 7.340 ± 0.02) with ENK administration. The he matocrit of the arterial blood also showed little change (43.5 ± 2.8 to 42. 4 ± 3.6%).
DISCUSSION
In view of the evidence obtained in pharmacolog ical, biochemical, and behavioral studies, the possi bility must be considered that several of the actions of naloxone may be unrelated to its opiate receptor blocking properties. As pointed out by Badawy et aI. (1983) , naloxone antagonizes or prevents a va riety of effects exerted by morphine and by non- opiate drugs on several metabolic systems, such as the brain tryptophan metabolism, tryptophan dis position, liver heme metabolism, liver pyridine di nucleotide metabolism, and lipolysis. Naloxone can affect the calcium flux and cyclic adenosine mono phosphate metabolism, and at high does it may have antioxidant properties (Sawynok et aI., 1979; Koreh et aI., 1981) . These non-opiate-related ef- Values are means ± SE; n = 7. p value evaluated by Student's t test.
MABP (mm Hg); cerebral blood volume (vol%); cerebrocortical blood flow (ml/l00 g/min); cerebral vascular resistance (mm Hg/mll 100 g/min); C, contralateral to MCA occlusion; I, ipsilateral to MCA occlusion.
J Cereb Blood Flow Metab, Vol. 6, No.5, 1986 fects of naloxone could give rise to misleading con clusions when studying the consequences of blockade of opioid actions. Faden (1983) has pointed out another type of problem. There has been an expansion in the number of recognized endogenous opioids, which has been accompanied by an expansion in the number of recognized opiate receptor subtypes (Zukin and Zukin, 1981) . In view of the complexity of the endogenous opioid systems, caution should be exercised in proposing a role for endogenous opioid peptides in the pathophysiology of a specific disease.
In spite of these theoretical difficulties, it is un derstandable that the beneficial effects of naloxone (i.e., limitation of cerebral ischemia and improve ment of neurological functions following stroke) should be attributed to the opiate receptor blocking property of the drug, since the level of endogenous opioid peptides has been shown to increase signifi cantly during experimental brain ischemia. The question arises, however, as to whether or not in creased levels of endogenous opioid peptides pro duce effects in the brain ischemia similar to those of exogenous morphine administration. The cerebro vascular effects of opioid peptides have not yet been extensively studied under ischemic conditions of the brain. Insofar as we are aware, only one opioid peptide analogue, Sandoz FK 33824, has been investigated in this situation (Hosobuchi et aI., 1982h) .
In the present study, therefore, we investigated the effect of the stable enkephalin analogue EN K on CBF and CBV following unilateral MCA occlu sion in the cat. The main reason for selecting this analogue was the fast breakdown of the naturally occurring enkephalins. As reported by Szekely et al. (1977 Szekely et al. ( , 1978 , this analogue displays considerable analgesic activity following systemic as well as in tracerebroventricular administration. Not only does the compound cross the blood-barrier in ef fective concentrations, but it also has a relatively long half-life. Its action is broader than that of mor phine, including effects at 0and E-receptors as well as at f,L-receptors (Chang et aI., 1979; Wurster et aI., 1981; Szekely et aI., 1984) . We have previously demonstrated the utility of this analogue for inves tigating opiate effects on autonomic nervous system functions (Sandor et aI., 1985) , and in an other study we found that this compound can pro duce vasodilation in the pial arteries and veins of anesthetized cats (Korbari et aI., 1985) .
According to our present results, EN K further decreased the already reduced cerebrocortical blood flow in the ischemic hemisphere of anesthe-tized cats upon intracarotid administration. Since the animal was mechanically ventilated, changes in arterial Pco2, Po2, and pH were minimal with ENK administration. The hematocrit of the arterial blood was also unchanged. The observed hemodynamic changes could not therefore be explained by such small changes in arterial gases, pH, or hematocrit. We observed a systemic arterial pressure fall at the same time from 102 ± 8 to 68 ± 5 mm Hg (Table 2) . On this basis it might be interpreted that the de creased CBF in the ischemic hemisphere reflected merely the systemic pressure fall. However, there was a statistically significant increase in cortical vascular resistance to the ischemic hemisphere. The observed additional reduction of cortical blood flow following ENK administration in the ischemic brain corresponds well with our own previous finding that topical application of Met-enkephalin to the cortex led to a dose-dependent decrease of cerebrocortical parenchymal tissue blood flow and tissue P02 in awake cats (Sandor et aI., 1983) .
The results obtained with naloxone in the present study support the view that naloxone may improve both the cortical blood flow and the CBV in the ischemic brain. In contrast neither cortical blood flow nor CBV showed any significant change in the intact hemisphere at the same time. These findings differ in part from those obtained by Levy et aI., (1982) , who found that reversal of ischemic neuro logical deficits by naloxone was accompanied by a decrease in local blood flow, but also observed that naloxone had no effect on blood flow in the intact hemisphere following unilateral MCA occlusion in cats. Since in our study the decrease in cerebrocor tical vascular resistance following naloxone admin istration did not reach the level of statistical signifi cance (Table 1) , the increased blood flow and blood volume in the ischemic hemisphere might have been a consequence of the systemic arterial pres sure elevation occurring under our experimental conditions.
In conclusion it can be said that intracarotid ad ministration of the stable enkephalin analogue ENK resulted in similar effects to those observed by other authors following exogenous morphine ad ministration in brain ischemia. The enkephalin ana logue produced a further reduction of the already reduced cortical blood flow in the ischemic brain. Our findings support the view that naloxone does have beneficial effects in experimental brain isch emia, and it seems likely that such effects are opiate receptor-mediated changes and not merely the result of other non-opiate-related side effects of the drug. These findings suggest that besides other factors, central opioid mechanisms may also play a role in the pathophysiology of stroke-in duced changes of the cerebral circulation.
